Novartis Still On Track to Buy Majority In Alcon

By on December 7, 2008 in All

Novartis Chief Executive Daniel Vasella confirmed that Novartis is still on track to buy a majority share in Alcon in a report December 5, 2008 in Switzerland

Bookmark and Share

About Editor

View all posts by Editor →

,

Trackbacks/Pingbacks

  1. From Allergan To Advanced Medical Optics To Abbott In 7 Years — the international medical market place - January 12, 2009

    [...] Makes sense with one possible caveat – ophthalmology requires focus and the most successful companies have been largely independent. This changes with the Abbott acquisition, but also comes short on the heels of the new majority shareholding by Novartis in Alcon… [...]

Leave a Reply